Inflammation-Targeted Molecular Imaging for Myocarditis: Recent Advances in Target Mechanisms, Probe Development, and Translational Applications
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00450 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Zhou Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China. Hauptthemen laut MEDLINE: Myocarditis, Molecular Imaging, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine Foundation of Guangdong Province.
Abstract (Originalsprache)
Inflammation is the key feature of myocarditis, which remains challenging to diagnose due to its complex etiology and nonspecific clinical presentation. In recent years, inflammation-targeted molecular imaging has become a research priority, and noninvasive monitoring of cardiac inflammation is expected to improve the accuracy of clinical diagnosis. This review focuses on the molecular imaging probes and targets for myocarditis in radionuclide imaging, ultrasound imaging, and magnetic resonance imaging (MRI), discussing the characteristics and applications of each probe-target combination and their potential limitations. Molecular targeted imaging approaches for inflammatory cell phenotypes, metabolic pathways, and endothelial cell markers hold significant potential for clinical translation and allow for early detection and treatment monitoring of myocarditis, thereby enabling better patient care and improving clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
- Department of Radiology, Zhongxian People's Hospital, Chongqing 404300, China.
- Department of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
- Department of Nuclear Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
- Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
- Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
ORCID-Profile: Lan Yao
Förderung
- National Natural Science Foundation of China
- Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine Foundation of Guangdong Province
Zitieren
APA
Ye, Z., Fu, L., Ye, X., Lu, X., Zhang, F., Ran, Y., Zhu, M., Xu, D., & Yao, L. (2025). Inflammation-Targeted Molecular Imaging for Myocarditis: Recent Advances in Target Mechanisms, Probe Development, and Translational Applications. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00450
Vancouver
Ye Z, Fu L, Ye X, Lu X, Zhang F, Ran Y, et al. Inflammation-Targeted Molecular Imaging for Myocarditis: Recent Advances in Target Mechanisms, Probe Development, and Translational Applications. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00450
BibTeX
@article{Ye2025,
author = {Ye, Zhou and Fu, Linlin and Ye, Xi and Lu, Xin and Zhang, Fan and Ran, Yingqi and Zhu, Manman and Xu, Duo and Yao, Lan},
title = {Inflammation-Targeted Molecular Imaging for Myocarditis: Recent Advances in Target Mechanisms, Probe Development, and Translational Applications},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00450}
}
EUVIMED